A literature review revealed both supportive and contradictory findings: Guo et al. confirmed elevated METTL3 levels in LUAD and BLCA and linked METTL3 expression to immune cell abundance in LUAD, underscoring its role in the tumor microenvironment [91]. The gene discussed is METTL3; the disease is neoplasm.